# NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer \(Lots 1, 2, 3, 4 and 5\)

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Tender value: £624,000,000
- Published: 27 October 2023
- Planned start: 1 April 2024
- Planned end: 31 March 2028
- Stage: open_tender
- Procurement category: goods
- Notice ID: 6800212d-7fe3-47d8-9392-f1cdfc1a94e8-692798
- OCID: ocds-b5fd17-0765c867-813e-47be-9810-a64e99e63cc6

## Description

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer \(Lots 1, 2, 3, 4 and 5\) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 \(covering regions East of England, London, North of England and South East\)\. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family\.force\.com/s/Welcome\. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis\.co\.uk

## Related contract awards

- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [Provision of national e-portfolio 26/27](/contracts/ocds-b5fd17-7e027849-39ea-4eb8-8eb0-3b38f18dcca4): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/6800212d-7fe3-47d8-9392-f1cdfc1a94e8-692798)